Moreover, we performed flow cytometry analysis to evaluate TIGIT expression ex vivo in tumor, spleen, or lymph node as single cell suspensions, focusing on the CD45+, CD3+, CD4+, CD8+ and Treg populations (Figure 7B). This evidence concerns the gene PTPRC and neoplasm.